Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA adducts as a dosimeter for risk estimation.

S A Belinsky1, C M White, T R Devereux

  • 1National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.

Environmental Health Perspectives
|December 1, 1987
PubMed
Summary

This study reveals that the tobacco carcinogen NNK (4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone) activates via different pathways in rat lungs and nasal passages. Lower NNK doses increase DNA damage efficiency, particularly in Clara cells, suggesting a mechanism for its potent carcinogenicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical performance and potential clinical utility of the GenMark Dx ePlex® blood culture identification gram-positive panel.

Diagnostic microbiology and infectious disease·2022
Same author

Salvaging the dehisced glans penis.

Journal of pediatric urology·2018
Same author

The influence of resting blood pressure on muscle strength in healthy adults.

Blood pressure monitoring·2018
Same author

Molecular fingerprinting of principal neurons in the rodent hippocampus: A neuroinformatics approach.

Journal of pharmaceutical and biomedical analysis·2017
Same author

Breeding population fluctuations in some raptors.

Oecologia·2017
Same author

Fluctuations of observed breeding Rough-legged Hawks and Gyrfalcons: regularity reconsidered.

Oecologia·2017

Area of Science:

  • Toxicology and Carcinogenesis
  • Molecular Biology
  • Respiratory and Nasal Pathology

Background:

  • Tobacco-specific nitrosamines, such as NNK (4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone), are potent carcinogens.
  • Understanding the dose-response relationship of NNK-induced DNA damage is crucial for assessing cancer risk.
  • Cellular differences in metabolic activation can influence tissue-specific carcinogenicity.

Purpose of the Study:

  • To determine the dose-response for O6-methylguanine (O6MG) formation and cytotoxicity in rat lung and nasal mucosa after NNK administration.
  • To investigate potential differences in NNK activation pathways and alkylation efficiency across various tissues and cell types.
  • To explore the role of Clara cells and nasal mucosa regions in NNK-induced DNA damage.

Main Methods:

Related Experiment Videos

  • Fischer 344 rats were administered multiple doses of NNK (0.3 to 100 mg/kg/day).
  • Quantification of O6-methylguanine (O6MG) formation in lung and nasal mucosa tissues.
  • Analysis of O6MG accumulation and alkylation efficiency in specific lung cell populations (e.g., Clara cells) and nasal mucosa regions (respiratory vs. olfactory).

Main Results:

  • O6MG accumulated in the lung with increasing NNK dose, but the O6MG-to-dose ratio (alkylation efficiency) increased nonlinearly, rising significantly at lower doses.
  • Clara cells exhibited the highest O6MG concentrations, with alkylation efficiency increasing 38-fold as NNK dose decreased, suggesting a high-affinity activation pathway.
  • Nasal mucosa showed differential dose responses: nonlinear in respiratory mucosa and linear in olfactory mucosa, with increased alkylation efficiency at lower doses primarily in the respiratory region.

Conclusions:

  • Nonlinear dose-response for NNK-induced O6MG formation suggests the involvement of both low- and high-Km metabolic activation pathways.
  • A high-affinity NNK activation pathway in Clara cells may explain the potent carcinogenicity of NNK, especially at low exposure levels.
  • A low Km activation pathway for NNK is present in the nasal passages, predominantly localized in the respiratory mucosa.